Sage Journals: Discover world-class research

Abstract

Lifestyle medicine is an emerging field that uses targeted behavioral interventions to prevent and manage chronic diseases. This review examines how its six pillars; nutrition, physical activity, stress management, avoidance of risky substances, restorative sleep, and social connection relate to dermatologic health. Through a comprehensive literature review, we identified evidence linking lifestyle factors to skin disease outcomes. Ultraviolet (UV) exposure, for example, accelerates photoaging and skin cancer risk, while photoprotection helps prevent this damage. Allergen and irritant avoidance are essential in conditions like atopic and contact dermatitis. Nutrition impacts inflammation, barrier function, and oxidative stress, influencing diseases such as psoriasis and acne. Physical activity improves skin appearance and reduces systemic inflammation. Sleep quality regulates immune function, with poor sleep linked to flares in eczema and urticaria. Risky behaviors like tobacco and alcohol use correlate with more severe disease and poorer outcomes. Social connection improves quality of life and treatment adherence, especially in visible or stigmatized conditions. Validated assessment tools, including questionnaires and biomarkers, can guide risk stratification and personalized care. When adapted to patient context, lifestyle interventions offer non-pharmacologic strategies that enhance dermatologic treatment. This review underscores the need to integrate lifestyle medicine into dermatology for a preventive, patient-centered approach.

Keywords

lifestyle medicine dermatology skin disease nutrition exercise sleep stress tobacco alcohol social support chronic inflammation holistic care non-pharmacologic interventions behavior change patient-centered care

“The convergence of lifestyle medicine principles with dermatologic practice represents an evolution in how we conceptualize skin health and disease management.”

Introduction to Lifestyle Medicine

Lifestyle medicine is a medical specialty focused on using therapeutic lifestyle interventions to treat and reverse chronic conditions, as defined by the American College of Lifestyle Medicine founded in 2004.¹ Evidence-based strategies guide the prescription of lifestyle changes, shown to improve or reverse conditions like cardiovascular disease and metabolic syndrome.^1,2 Integrating nutrition, physical medicine, rehabilitation, and psychology, lifestyle medicine promotes overall health and disease prevention.

These lifestyle modifications not only improve specific conditions but enhance general well-being.³ For example, improving nutrition in a patient with hyperlipidemia can also improve sleep and energy levels. With chronic disease prevalence rising in the United States, growing research supports the relevance of lifestyle medicine in clinical care.⁴ Chronic dermatologic diseases, such as psoriasis, eczema, and rosacea, are influenced by lifestyle factors. Thus, applying lifestyle medicine principles may aid in managing these conditions.

Lifestyle medicine promotes a whole-person, individualized approach grounded in six pillars: nutrition, physical activity, stress management, avoidance of risky substances, restorative sleep, and social connection.¹ The first pillar emphasizes that increasing intake of minimally processed foods helps prevent and reverse lifestyle-related chronic diseases.⁵ The second pillar, physical activity, is crucial for preventing disease and improving health through 150-300 minutes of moderate or 75-150 minutes of vigorous aerobic activity weekly, plus strength training on at least two days.⁵ Stress management is the third pillar, aimed at reducing chronic stress, which raises the risk for cardiovascular and mental health disorders.^5–8 The fourth pillar focuses on avoiding risky substances like tobacco and alcohol, which are linked to chronic medical conditions.⁹ The fifth pillar, restorative sleep, is vital for attention, hunger, and insulin resistance, all of which contribute to chronic disease.⁵ The sixth pillar, social connection, is vital for emotional and physical health, as strong relationships improve cardiovascular markers like heart rate and blood pressure while social isolation increases morbidity and mortality.^5,11 SMART goals (specific, measurable, achievable, realistic, and time-bound) are encouraged to help patients achieve their personal goals within each of these pillars.

The principles of lifestyle medicine are applicable across all specialties. This review focuses on the influence of lifestyle factors, especially the six pillars, on dermatologic diseases. Relevant factors include UV exposure, allergens, diet, exercise, sleep, substance use, stress, and social support (Figure 1). We aim to summarize evidence showing how these factors affect outcomes of several common skin diseases and are relevant in considering personalized approaches to the management of dermatologic disease overall.

Figure 1.

Modifiable lifestyle factors that influence dermatologic disease.

Methods

A comprehensive literature search was performed using PubMed and Google Scholar through June 1st, 2025. The following keywords and Medical Subject Headings (MeSH) terms were used in various combinations: “lifestyle medicine,” “nutrition,” “diet,” “exercise,” “stress,” “sleep,” “alcohol,” “tobacco,” “psoriasis,” “acne,” “rosacea,” “atopic dermatitis,” “hidradenitis suppurativa,” and “skin disease.”

We included peer-reviewed clinical trials, systematic reviews, meta-analyses, observational studies, and relevant expert opinions that explored the relationship between lifestyle interventions and dermatologic outcomes in adults and adolescents. Articles were included if they specifically addressed one or more lifestyle pillars and a skin condition of interest. Studies were selected based on their quality, relevance, and applicability to clinical practice. Key findings were extracted regarding the type of intervention, dermatologic outcome measured, and any reported statistical significance or clinical relevance. Preference was given to studies with clearly defined interventions and quantifiable skin outcomes.

This review is not systematic and does not aim to provide a meta-analysis of outcomes. Rather, it highlights significant trends and recurring evidence supporting the integration of lifestyle-based approaches in dermatologic care. Limitations include potential selection bias and the heterogeneity of study designs, populations, and outcome measures among included articles.

Results and Discussion

UV Exposure

Ultraviolet (UV) radiation contributes to both acute cutaneous effects, such as erythema and sunburn, and long-term consequences including photoaging, pigmentary disorders, and increased risk of skin cancer.^{12,13,14,15,16,17} UVB radiation primarily induces direct DNA damage through the formation of cyclobutene pyrimidine dimers and 6-4 photoproducts,^15,18 while UVA penetrates deeper into the dermis and generates reactive oxygen species that damage cellular proteins, lipids, and DNA.¹⁶ Together, these mechanisms accelerate skin aging and increase the risk of nonmelanoma skin cancers and melanoma.^12,19 UV radiation also impairs skin barrier integrity, disrupts immunologic surveillance, and contributes to pigmentary changes.^15,20

Given the wide variability in UV susceptibility and exposure, photoprotection strategies should be personalized based on both intrinsic factors (such as skin phototype, age, genetic predisposition, and other skin conditions) and extrinsic factors (such as occupational exposure, geographic location, and access to protective resources).^14,17,20 Individuals with Fitzpatrick skin types IV-VI, while at lower risk for skin cancer, are more prone to pigmentary disorders such as melasma and post-inflammatory hyperpigmentation.^14,21,22 For these individuals, tinted sunscreens with visible light protection (e.g., iron oxides) and non-nanosized inorganic filters offer both efficacy and cosmetic compatibility.¹⁴ Similarly, children may benefit from oil-based inorganic sunscreens containing zinc oxide or titanium dioxide, which are less likely to cause irritation or systemic absorption.¹⁴ Older adults may require heightened photoprotection due to cumulative photodamage and frequent use of photosensitizing drugs.^14,23

People with occupations primarily located outdoors, including those in construction or landscaping, often experience high levels of occupational UV exposure and should receive individualized counseling that emphasizes consistent use of sunscreen, protective clothing, and scheduling outdoor tasks outside of peak UV hours.^{12,15,24,25,26} Geographic location also plays a role—UV intensity is greater at higher altitudes and closer to the equator, requiring more rigorous protection in these regions.²⁷ Patients with inflammatory or photosensitive skin conditions, or those undergoing phototherapy, may also require individualized adjustments to their photoprotection regimens.^17,22 For instance, individuals with lupus or dermatomyositis may benefit from sunscreens that offer visible light and UVA protection to prevent flares, while those undergoing PUVA therapy require stricter sun avoidance outside treatment sessions compared to those receiving narrowband UVB.^17,22

Emerging strategies, including sunscreens fortified with DNA repair enzymes like photolyase, have shown potential in improving photodamage markers among high-risk individuals with actinic keratoses.^14,28,29 Beyond pharmacologic and topical interventions, behavioral modifications such as avoiding midday sun, seeking shade, and wearing protective clothing are fundamental.¹⁴ Ultimately, precision photoprotection reinforces the broader goals of lifestyle-based dermatologic care, ensuring that interventions are adapted not only to an individual’s biology, but also to their daily environment, social determinants, and risk profile.

Allergens

Allergic and irritant exposures exemplify how environmental factors intersect with multiple lifestyle medicine pillars (nutrition, stress, sleep, risky substances, physical activity), influencing not only direct skin contact but also systemic immune reactivity. Understanding these interconnections is crucial for comprehensive dermatologic care, as allergic and irritant exposures are key contributors to a range of dermatologic conditions, particularly allergic contact dermatitis (ACD) and atopic dermatitis (AD). ACD, a type IV delayed hypersensitivity reaction, affects up to 20% of the population.^{30,31,32,33,34} Irritant contact dermatitis (ICD), which accounts for up to 80% of contact dermatitis cases, results from non-immunologic inflammation caused by repeated exposure to substances like solvents, surfactants, and alkalis.³² Although distinct in pathophysiology, both ACD and ICD arise from a combination of environmental exposures and intrinsic susceptibility, particularly skin barrier integrity.^31,33,34

Genetic disruptions in barrier function, most notably filaggrin (FLG) mutations, are strongly associated with AD and increased sensitization to allergens like nickel.^31,35,36 Inflammation further comprises the skin barrier, allowing even weak allergens such as lanolin, parabens, tocopherol, acetate (vitamin E), and commensal antigens to provoke immune responses.^33,37 Food proteins have also emerged as cutaneous sensitizers, especially in individuals with chronic hand dermatitis from wet work or in those with underlying AD.^33,38

Occupational exposures vary widely across industries and are major contributors to allergen sensitization.^39,40 High-risk professions include health care workers, hairdressers, agricultural laborers, construction workers, and those in manufacturing or food processing industry.^39,40 In health care, common triggers include formaldehyde and rubber accelerators found in gloves, such as carba and thiuram mix.^39,40 Hairdressers are frequently exposed to allergens like nickel in tools, p-phenylenediamine (PPD) in hair dyes, and ammonium persulfate in bleaches.^{39,40,41,42,43} Construction and manufacturing workers often encounter epoxy resins and chromates, while agricultural laborers may be sensitized to pesticides or plant proteins.^39,44 In agriculture, dermatitis may result from both active ingredients and inactive components such as emulsifiers and surfactants, though standardized patch testing for these exposures remains lacking.¹⁰ Jewelry-related allergens—including nickel, gold, and palladium—also remain common, particularly in individuals with piercings.^40,45

Diagnosis and personalized management depend heavily on patch testing. Standardized panels like the Thin-layer Rapid-Use Epicutaneous Test are widely used, though custom trays are often required for occupational or uncommon allergens for individual patients.³² Determining clinical relevance requires linking positive reactions to real-world exposures—a process guided by thorough occupational and personal histories, ingredient reviews, and product labeling. Resources like the Contact Allergen Management Program (CAMP) can generate personalized lists of safe products for each patient, improving adherence to allergen avoidance plans.³²

Lifestyle-based interventions remain foundational. Patients should minimize wet work, use gentle skincare products free of fragrances and preservatives, and apply emollients regularly to restore barrier function.^32,34 In occupational settings, changing glove materials, substituting allergenic products, and adjusting workflows can prevent recurrences.³⁹ These strategies, when guided by patch testing and tailored to individual exposures, offer a precision-based approach to managing chronic dermatitis. Integrating allergen avoidance into dermatologic care reflects the principles of lifestyle medicine: empowering patients to improve skin health by identifying and mitigating modifiable environmental risks.

Diet

Diet affects overall skin health and a variety of dermatological conditions.^46,47 Several nutrients and bioactive compounds are thought to contribute to skin health through diverse mechanisms, including antioxidant activity, barrier support, anti-inflammatory effects, and regulation of cellular repair and regeneration.^48,49,50 Vitamin A and its derivatives, including carotenoids like β-carotene and lycopene, support immune function, reduce UV-induced damage, and improve conditions such as acne, atopic dermatitis, hidradenitis suppurativa (HS), and photoaging.^51,52,53 Vitamin C enhances collagen and elastin synthesis, inhibits melanin production, and provides systemic antioxidant protection against UV radiation and inflammatory skin disorders.^48,51,54 Vitamin D, synthesized in the skin, contributes to immune regulation, reduces inflammation in conditions like psoriasis and HS, and helps protect against UV-mediated cellular damage.^53,54,55 Vitamin E acts as a lipid-soluble antioxidant that stabilizes cell membranes, supports collagen integrity, and may mitigate inflammation and photoaging.^54,56 Essential fatty acids, particularly long-chain omega-3s such as EPA and DHA, play a key role in maintaining the skin barrier, modulating inflammation, and may reduce disease severity in atopic dermatitis, psoriasis, and acne.^51,57,58 Polyphenols, including flavonoids like quercetin and kaempferol, protect against oxidative stress, preserve collagen and elastin, modulate inflammation, and may benefit skin structure and appearance when consumed in whole-food form.^45,59,60 Zinc is concentrated in the epidermis and can support wound healing, immune defense, UV protection, and treatment of inflammatory dermatoses and HS.^54,61–63 Copper facilitates collagen maturation, melanin synthesis, and angiogenesis, and copper peptides may enhance wound healing and skin regeneration.^48,64 Selenium, through its role in antioxidant enzymes, can protect against UV-induced DNA damage and may reduce the risk of keratinocyte carcinomas while supporting anti-aging effects.^50,51,53,65

Deficiencies in key micronutrients can result in characteristic cutaneous manifestations across multiple sites, including the scalp (alopecia: zinc, copper; hypopigmentation: selenium, copper; pili torti: copper), oral mucosa (gingival swelling or hemorrhage: vitamin C; angular cheilitis: zinc), nails (dystrophy: zinc; leukonychia or paronychia: selenium), and skin (seborrheic dermatitis: copper; follicular hyperkeratosis: vitamin A; perifollicular hemorrhage; hyperkeratotic papules: vitamin C; hidradenitis suppurativa: iron, zinc, vitamin A, vitamin D, vitamin B12).^65,66,67 Dietary modifications may support management of inflammatory and autoimmune skin conditions such as psoriasis (address obesity, diabetes, dyslipidemia),^47,68,69 atopic dermatitis (allergen avoidance),^70,71 acne (low-glycemic, anti-inflammatory diet), and HS (low-glycemic, non-dairy, mediterranean diet).^47,66,72 Moreover, evidence suggests that a diet rich in fruits and vegetables, along with the intake of vitamins E and A, selenium, polyphenols, curcumin, lycopene, and grape seed extract, may offer protective effects against nonmelanoma skin cancers.^47,48,74

While several of these relationships are theorized or shown in preliminary data, there remains a lack of high-quality evidence to substantiate “gold standard” guidelines for a skin-healthy diet. One sample diet tailored to dermatology proposed target micronutrient levels that emphasize whole foods and limit ultra-processed items, mirroring the principles of the Mediterranean, DASH, and Healthy Eating Index diets.⁴⁸ Further research is needed to refine optimal maintenance intake levels and possible supplementation for specific dermatologic conditions.

Exercise

Exercise reduces the thinning of the stratum corneum and increases mitochondrial biogenesis, thus slowing skin cell aging.^75,78 To elicit these effects, exercise should be aerobic and performed for at least four hours per week. Studies have also found exercise reduces the risk of psoriasis in women, potentially by modulating proinflammatory cytokines.⁷⁵ Exercise also affects dermatologic disease through enhanced wound healing. Increased healing rates were observed in people performing resistance exercises and physical activity for 90 minutes per week.⁷⁵ Regular exercise reduces free radical and oxidative stress damage in the skin, which may provide protection from skin neoplasms.⁷⁵ Additionally, aerobic and strength training exercise have long-term anti-inflammatory effects with regular practice, particularly in downregulation of TNF-alpha.⁷⁶ Psoriasis and dermatomyositis, two dermatologic diseases characterized by increased TNF-alpha, show marked improvement in patient function and reduced disease activity with exercise.⁷⁶ Overall, regular exercise of at least moderate intensity improves skin blood flow through vasodilation of cutaneous microvessels, enhances moisturization, strengthens skin structure, and improves skin appearance.⁷⁷

However, short-term, initial exercise produces a proinflammatory response that gradually subsides with consistent, regular training.⁷⁸ While regular exercise benefits dermatologic disease through the mechanisms described above, environmental factors can mitigate these beneficial effects. For instance, patients with eczema who meet their weekly exercise requirements in chlorinated swimming pools may experience worsening skin conditions due to the environmental exposure.⁷⁷ Additionally, patients who neglect post-exercise hygiene practices, including failing to wash their face and skin and allowing sweat, dirt, or makeup to remain on the skin, will experience skin irritation and develop dermatologic conditions such as acne vulgaris.⁸² Therefore, patients should recognize that both irregular exercise patterns and environmental factors can promote skin inflammation.⁷⁷

Exercise intensity is measured using metabolic equivalents (METs), which quantify oxygen consumption relative to resting levels.⁷⁹ Regular beneficial exercise consists of more than four hours per week of high-intensity aerobic activity. Vigorous exercise corresponds to a MET score greater than 6, typically achieved through aerobic or calisthenic exercises. Longer workouts with higher MET scores correlate with greater reductions in inflammatory dermatologic disease risk, particularly psoriasis.^75,80 Conversely, physical inactivity harms dermatologic outcomes. Atopic dermatitis, for example, has been specifically linked to lower average physical activity levels.⁸¹ Thus, sedentary patients may be more susceptible to dermatologic diseases, as exercise serves as a protective factor.

Current physician consensus guidelines recommend at least 150 minutes weekly of moderate-intensity aerobic activity plus two additional days of muscle-strengthening exercises. In MET terms, this corresponds to scores ranging from 5-8+ for moderate-to-intense activity.⁸³ These activities include walking and running at a 10-minute mile pace. Physicians, including dermatologists, should discuss exercise as a lifestyle factor with patients given its significant impact on chronic disease management.

Sleep

Immune function, which is tightly interlinked with inflammatory dermatologic diseases, is modulated by sleep and the circadian rhythm. Proinflammatory cytokines increase with sleep deprivation, serving as potential drivers of inflammatory skin disease. Natural killer cells are lost in sleep deprivation, making individuals prone to infections that can result in cutaneous manifestations.⁸⁴ During sleep, the skin is able to repair and regenerate, so accelerated skin aging and weak barrier functioning are associated with inadequate sleep.⁸⁵ Melatonin falls with increased inadequate sleep, which not only is essential for circadian rhythm but for antioxidant function within the skin barrier.⁸⁵ During sleep, there is a net transepidermal water loss which can lead to increased pruritus at night.⁸⁴ Overall, sleep and dermatologic disease have a complex relationship, intermediated by immunology and skin physiology.⁸⁵ Specifically, atopic dermatitis, psoriasis, chronic urticaria, skin infections, and pruritus are skin diseases associated with disorders that alter normal sleep, like obstructive sleep apnea, narcolepsy, and parasomnia.⁸⁴

Although sleep deprivation can amplify dermatologic diseases, dermatologic diseases can impede sleep. Nocturnal pruritus, a manifestation of skin infection (Sarcoptes scabiei, Staphylococcus aureus), atopic dermatitis, psoriasis, and urticaria, can result in sleep disturbances when at a high enough intensity for the individual.⁸⁴ Chronic pruritus significantly impairs sleep quality, productivity, and mental health, making it essential for dermatologists to assess these lifestyle impacts when treating affected patients.⁸⁴

Patients with poor sleep quality, as assessed through validated instruments like the Pittsburgh Sleep Quality Index, should receive comprehensive interventions including sleep hygiene counseling, lifestyle modifications, and when appropriate, pharmacological treatments such as melatonin or sedatives to reduce inflammation and prevent the onset or exacerbation of dermatologic conditions. The American College of Lifestyle Medicine recommends a full 7-8 hours of sleep for adults each night as the standard of self-care and for the prevention of chronic disease, although this measure increases in infants and childhood.^5,10 For patients experiencing new-onset inadequate sleep due to the pruritus or other distressing symptoms of a dermatologic disease, comprehensive management may require a dual approach addressing both the underlying skin condition and the resulting sleep disturbance^87,88. Dermatologic treatment may involve topical or systemic therapies (including hydrocortisone, triamcinolone, diphenhydramine) aimed at reducing inflammation, itch, and discomfort, while concurrent sleep-focused interventions, such as cognitive behavioral therapy for insomnia (CBT-I), sleep hygiene education, or short-term pharmacological aids, can help restore restful sleep and improve overall quality of life. This multidisciplinary approach is particularly important, as untreated sleep disruption can exacerbate dermatologic symptoms and contribute to a cycle of worsening disease severity and psychological distress.⁸⁵

Smoking

Tobacco use exerts widespread systemic effects through oxidative stress, immune dysregulation, and impaired angiogenesis,⁵ all of which have direct implications for skin health and disease management. From a lifestyle medicine perspective, tobacco exposure should be considered a modifiable risk factor for numerous dermatologic conditions. Smoking through any delivery method—including cigarettes, vaping, or hookah—results in significant toxicant exposure that produces adverse cutaneous effects.⁸⁶ Among these methods, cigarettes pose the greatest risk due to their exceptionally high levels of harmful compounds, including particulate matter, reactive gases, heavy metals, and N-nitrosamines, which accelerate skin aging, promote chronic inflammation, and impair wound healing processes.⁸⁶

Clinically, smoking hastens skin aging through increased matrix metalloproteinase activity, depletion of antioxidants, and disruption of TGF-β signaling pathways.^90,91,92 These changes result in collagen degradation, elastosis, and the characteristic “smoker’s face,” marked by periorbital wrinkling, atrophy, and yellowish discoloration.⁹² Among current smokers in a study done in 1999, awareness of smoking’s link to premature facial aging was significantly lower than among former smokers, yet nearly 25% of smokers (especially younger ones) believed this information would influence quit decisions.⁸⁹ These findings suggest that incorporating premature aging messages into tobacco control campaigns could be an effective cessation strategy, particularly given smokers’ own recognition of its potential impact on quit attempts.^89,92

Tobacco is also implicated in oncogenesis. Beyond its systemic carcinogenicity, it contributes to increased risk for squamous cell carcinoma and anogenital keratinocytic malignancies, particularly in HPV-positive individuals.^86,94,95,96 Though associations with basal cell carcinoma and melanoma are inconsistent,^86,97,98 the immunosuppressive effects of smoking are especially concerning in high-risk populations and patients should be counseled appropriately. Conversely, transdermal nicotine patches, while serving as valuable smoking cessation aids, may paradoxically undermine quit attempts by causing irritant or allergic contact dermatitis in some patients, potentially discouraging continued use of this therapeutic intervention.⁹⁴

In inflammatory skin diseases, tobacco use is a well-established risk factor. Smokers are significantly more likely to develop psoriasis and palmoplantar pustulosis, with a dose-dependent relationship.^99,100 Hidradenitis suppurativa is strongly linked to smoking, and while cessation may not fully reverse disease risk, it can lead to symptomatic improvement.^101,102 There is also evidence to suggest that smoking is associated with atopic dermatitis and allergic and irritant contact dermatitis.^102,103 Autoimmune diseases like systemic and cutaneous lupus erythematosus are also exacerbated by smoking, which is associated with higher disease activity and reduced response to standard treatments such as hydroxychloroquine.^{104,105,106,107}

While a few conditions, including pemphigus vulgaris, Behçet disease, and pyoderma gangrenosum, have shown paradoxical improvements with tobacco use,^86,108,109 these findings are preliminary and should not alter cessation recommendations. In clinical practice, smoking cessation should be framed not only as a cardiovascular or oncologic intervention but also as a dermatologic one, as visible skin improvements and reduced disease burden can serve as powerful motivators.⁸⁹ While dedicated tobacco cessation counseling led by dermatologists may not be feasible given high patient volumes and time constraints, every physician has an ethical obligation to remind patients about smoking’s detrimental effects on health and encourage cessation. Even brief interventions in the dermatology setting can be impactful, particularly when patients can directly observe smoking-related skin damage and understand the potential for visible improvement upon quitting.^86,89,92

Alcohol

Alcohol disrupts cardiovascular, immune, and hemostatic systems through both acute and chronic effects, contributing to cutaneous manifestations.¹¹⁰ It alters vascular tone and peripheral circulation, impairs cellular immunity by reducing T cell and neutrophil function, and disrupts coagulation through defective platelet production and aggregation.^111,112 These systemic changes help explain the diverse skin findings observed in individuals with alcohol use. Chronic use is associated with cutaneous signs such as jaundice, pruritus, pigmentary changes, urticaria, alterations in hair and nails, and oral mucosal changes.¹¹³ Alcohol-related liver dysfunction may underlie many of these findings (particularly jaundice, pruritus, and spider angiomas) while vascular abnormalities such as telangiectasias, palmar erythema, caput medusae, and flushing may result from hepatic decompensation or direct vasodilatory effects of ethanol.¹¹⁰ Additional vascular manifestations include plethoric facies, unilateral nevoid telangiectasia, and corkscrew scleral vessels. Nail abnormalities commonly observed include Terry’s nails, red lunulae, koilonychia, and clubbing, while hyperpigmentation can reflect systemic effects or nutritional deficiencies.¹¹⁰

Oral manifestations of chronic alcohol use include black hairy tongue, glossitis, leukoplakia, and parotid swelling, often resulting from poor oral hygiene, nutritional deficiencies, or immune suppression.^110,113 Other alcohol-associated conditions with skin involvement include Dupuytren’s contracture, Madelung’s disease, and coagulopathy.¹⁰⁶

Alcohol is a known exacerbating factor for chronic inflammatory skin diseases such as psoriasis, rosacea, and discoid eczema.^{110,113,114,115,116} Patients with chronic inflammatory conditions such as psoriasis or eczema are at increased risk for alcohol use disorder, with studies reporting prevalence as high as 30% based on CAGE (Cut down, Annoyed, Guilty, Eye-Opener), AUDIT-C (Alcohol Use Disorders Identification Test-Consumption), and MAST (Michigan Alcohol Screening Test) questionnaires.^117,118 Alcohol use in these populations is not merely incidental but may reflect attempts to cope with psychological distress, and impaired quality of life. Evidence suggests alcohol may also contribute to decreased response to treatment, including biologics.¹¹⁹ Given these findings, routine alcohol screening using tools such as AUDIT-C, CAGE, or the single alcohol screening question should be integrated into dermatologic care for patients with chronic inflammatory conditions or other dermatologic disease with high burden. Additionally, alcohol is an established risk factor for skin infections and certain malignancies, including basal cell carcinoma and melanoma, potentially due to immunosuppression and oxidative stress associated with chronic intake.^120,122 Physicians should be aware of the systemic and cutaneous effects of alcohol use, incorporate appropriate screening and counseling into dermatologic care, and communicate findings of unhealthy alcohol consumption to the patient’s primary care provider to ensure coordinated, multidisciplinary management that addresses both dermatologic and systemic health concerns.

Stress and Trauma

Stress plays a significant role in skin health through dysregulation of the neuroendocrine-immune (NEI) axis. Activation of the hypothalamic–pituitary–adrenal (HPA) axis and sympathetic nervous system leads to elevated cortisol, catecholamines, and proinflammatory cytokines such as IL-1β, IL-6, and TNF-α.^122,123 These mediators impair skin barrier function, delay wound healing, and disrupt keratinocyte differentiation, increasing susceptibility to inflammation and infection.¹²⁴ Acute stress can heighten itch via mast cell activation and neuropeptide release, while chronic stress contributes to sustained immune dysregulation and disease flares.

Dermatoses like psoriasis, atopic dermatitis, and alopecia areata are particularly sensitive to stress. In psoriasis, increased expression of corticotropin-releasing hormone (CRH) and CRH receptor 1 in lesional skin suggests local HPA axis dysregulation may perpetuate inflammation.¹²⁵ Psychological stress may also promote disease chronicity through expansion of tissue-resident memory T cells.¹²⁷ Moreover, skin disease itself can cause psychosocial distress, creating a feedback loop that worsens both psychological and dermatologic outcomes.¹²⁶

Stress can be assessed using self-report tools such as the Perceived Stress Scale (PSS) and Dermatology Life Quality Index (DLQI), which measure emotional burden and quality of life related to dermatologic disease.^128,129,130 Biomarkers like salivary cortisol and heart rate variability provide physiologic insights.¹³¹ These measures also assist with risk stratification, helping identify patients more likely to experience flares or impaired treatment response under stress.^122,123

Management strategies can be personalized based on stress sensitivity. Patients with high perceived stress may benefit from cognitive behavioral therapy, mindfulness-based stress reduction, or guided imagery. Early studies have demonstrated that mindfulness-based interventions may improve outcomes in psoriasis. One pilot study evaluated a structured eight-week mindfulness-based cognitive therapy program among individuals with psoriasis and found that participation led to improved illness perceptions and reduced distress, supporting the role of mindfulness in addressing the psychosocial burden of the disease.¹³² Another randomized controlled trial tested an eight-week mindfulness-based stress reduction program delivered alongside standard phototherapy or photochemotherapy for moderate-to-severe psoriasis. Participants in the mindfulness-based stress reduction program showed significantly faster rates of skin clearing compared to those receiving phototherapy alone, suggesting that stress reduction can meaningfully augment treatment response through psychoneuroimmunologic mechanisms.¹³³

Such interventions are increasingly recognized as effective complements to medical therapy. Incorporating these approaches into dermatologic care may help disrupt the stress–skin disease cycle and enhance both cutaneous and mental health outcomes.^134,135

Social Support

Social support significantly influences skin health and disease outcomes. High levels of support can buffer psychosocial stress, a known trigger for flares in chronic inflammatory conditions such as psoriasis and atopic dermatitis.¹³⁵ Patients with strong support networks often report better quality of life, fewer depressive symptoms, and greater acceptance of their disease.¹³⁶ Conversely, individuals with limited or poor-quality support tend to experience increased psychological burden. For example, vitiligo patients with low perceived support exhibit significantly higher levels of depression and distress, underscoring the psychosocial weight of visible skin conditions.¹³⁸ Social support likely functions as a protective factor within the brain–skin axis, mitigating inflammatory pathways through stress modulation.

Validated tools such as the Multidimensional Scale of Perceived Social Support (MSPSS) and the UCLA Loneliness Scale can help quantify patients’ social environments.¹³⁸ In dermatology, quality-of-life measures like the Dermatology Life Quality Index (DLQI) capture the emotional and social dimensions of disease burden, indirectly reflecting the impact of support systems.¹³⁷ Monitoring these indices in clinical settings can help identify individuals whose psychosocial well-being is declining. Support level also informs clinical risk stratification. Patients with low support show consistently worse quality of life and more severe depressive symptoms, particularly in psoriasis and vitiligo.^136,138,139,¹⁴⁰ Crucially, inadequate support can undermine treatment adherence. Studies show that tangible forms of assistance, such as help with medication routines, are associated with higher adherence rates and better therapeutic outcomes.¹³⁶

Personalizing dermatologic care based on social support can improve both mental and physical health. For patients with minimal support, referrals to support groups, psychoeducational programs, or digital communities may foster connection and resilience. Reinforcing strong support networks in well-connected patients can likewise enhance adherence and engagement, supporting a more holistic, lifestyle-informed model of dermatologic care.

Conclusion

The convergence of lifestyle medicine principles with dermatologic practice represents an evolution in how we conceptualize skin health and disease management. This comprehensive review has elucidated the intricate mechanisms through which the six pillars of lifestyle medicine—nutrition, physical activity, stress management, substance avoidance, restorative sleep, and social connection—modulate cutaneous pathophysiology across diverse dermatologic conditions. The evidence demonstrates that these lifestyle factors operate through complex, interconnected pathways involving neuroendocrine signaling, immune modulation, barrier function regulation, and psychosocial determinants of health, collectively influencing disease susceptibility, severity, and treatment responsiveness (Table 1).

Table 1.

Summary of Impact(s) of Lifestyle Factors on Dermatologic Disease.

Lifestyle Factor	Impact
UV Exposure	• UVA → direct DNA damage → photoaging, skin cancer^{12,13,14,15,16,17,18}
	• UVB → reactive oxygen species → photoaging, skin cancer^{12,13,14,15,16,17,18}
	• UV radiation → impaired skin barrier integrity, disrupted immunologic surveillance, increased pigmentary changes^15,16,21
Allergens/Irritants	• Exposure to allergen in addition to intrinsic susceptibility (FLG mutations) → allergic contact dermatitis, irritant contact dermatitis, exacerbation of atopic dermatitis^31,32,33
Allergens/Irritants	• Inflammation → compromised skin barrier → weak allergens (lanolin, parabens, tocopherol, acetate (vitamin E), and commensal antigens) provoke immune responses^34,38
Diet	• Vitamin A, C, D, E, omega-3s, etc. → barrier repair, reduced inflammation, protection against oxidative stress^52,58,59,62
Diet	• Nutrient deficiency → alopecia, nail dystrophy, dermatitis^66,69,70,73
Exercise	• Increased skin blood flow, hydration, and mitochondrial function, wound healing^48,75,76,77
Exercise	• Reduced skin aging, TNF-alpha & oxidative stress^48,75,76,77
Sleep	• Sleep deprivation → proinflammatory cytokines, weakened skin barrier → worsening dermatologic conditions (dermatitis, psoriasis, etc.)^83,84
Tobacco use	• Tobacco → collagen degradation, elastosis, worsened dermatologic disease (psoriasis, lupus)^5,47
Tobacco use	• Increased risk of squamous cell carcinoma, keratoacanthomas, hidradenitis suppurativa^86,93,94
Alcohol use	• Alcohol → decreased vascular tone, immunity, and coagulation → pruritus, jaundice, pigmentation change, vascular lesions, exacerbation of dermatologic disease (psoriasis, rosacea, dermatitis)^{106,107,108,109}
Alcohol use	• Increased risk of skin infection, basal cell carcinoma, melanoma, nutrient deficiency dermatoses^116,117
Stress	• Increased cortisol, cytokines, mast cell activation → triggers or worsens psoriasis, dermatitis, alopecia^{118,119,120,121}
Stress	• Impaired barrier function and wound healing^120,121
Social Support	• Decreased psychosocial stress → protective against psoriasis, dermatitis, chronic skin conditions¹³³
Social Support	• Improved quality of life and treatment adherence^133,135

The integration of lifestyle medicine principles into dermatologic practice requires a shift from purely pharmacologic approaches toward personalized, multidisciplinary care models. Practical implementation begins with incorporating validated assessment tools such as the DLQI, PSQI, and stress scales to identify high-risk patients who may benefit from lifestyle interventions. For patients with chronic inflammatory conditions like psoriasis or atopic dermatitis, addressing modifiable lifestyle factors—through dietary modification, stress management techniques, exercise counseling, and substance cessation—can meaningfully improve treatment outcomes while simultaneously addressing common comorbidities.

The therapeutic multiplicity of lifestyle interventions offers particular advantages in dermatology, where conditions often have systemic implications. Dietary interventions targeting inflammatory pathways benefit both skin disease and cardiometabolic health. Exercise recommendations reduce inflammatory markers while supporting wound healing and photoprotection. Stress management techniques can break the cycle of psychological distress and disease flares that characterizes many chronic dermatoses.

Clinical implementation challenges include the need for interdisciplinary collaboration, extended consultation times, and patient adherence to long-term behavioral changes. However, the potential for sustained disease improvement, reduced medication dependence, and enhanced quality of life justifies investment in these approaches. Digital health platforms and community resources can extend therapeutic reach beyond traditional clinical encounters, supporting sustained behavioral change.

Future research priorities should focus on standardized lifestyle intervention protocols and long-term cohort studies incorporating real-world data to establish optimal dosing and timing of interventions. The development of precision medicine approaches that account for genetic susceptibility, environmental factors, and individual stress reactivity represents a particularly promising direction.

Dermatologists are uniquely positioned to champion lifestyle medicine integration given the visible nature of skin disease and its profound psychosocial impact. By addressing lifestyle factors alongside conventional treatments, dermatologic practice can evolve toward a more comprehensive, preventive model that treats the whole person rather than isolated cutaneous manifestations. This approach not only improves dermatologic outcomes but positions the specialty at the forefront of patient-centered, sustainable health care delivery.

Footnotes

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article

ORCID iDs

Maya Akbik

Sarah Lee

Data Availability Statement

The information pulled that support the findings of this study are openly available in PubMed as listed in the reference section.*

References

American College of Lifestyle Medicine . American College of Lifestyle Medicine website. https://lifestylemedicine.org/. Accessed 23 April 2025.

Lippman

Stump

Veazey

, et al. Foundations of lifestyle medicine and its evolution. Mayo Clin Proc Innov Qual Outcomes. 2024;8(1):97-111. doi:10.1016/j.mayocpiqo.2023.11.004

Phillips

Frates

Park

. Lifestyle medicine. Phys Med Rehabil Clin. 2020;31(4):515-526. doi:10.1016/j.pmr.2020.07.006

Benavidez

Zahnd

Hung

Eberth

. Chronic disease prevalence in the US: sociodemographic and geographic variations by zip code tabulation area. Prev Chronic Dis. 2024;21:230267. doi:10.5888/pcd21.230267

American College of Lifestyle Medicine . Pillar Booklet. American College of Lifestyle Medicine; 2023. Accessed 23 April 2025.

Adams

Kohlmeier

Powell

Zeisel

. Nutrition in medicine: nutrition education for medical students and residents. Nutr Clin Pract. 2010;25(5):471-480. doi:10.1177/0884533610379606

Thompson

Sallis

Joy

Jaworski

Stuhr

Trilk

. Exercise is medicine. Am J Lifestyle Med. 2020;14(5):511-523. doi:10.1177/1559827620912192

Chu

Marwaha

Sanvictores

, et al. Physiology, stress reaction. In: Statpearls. StatPearls Publishing; 2025. Updated May 7, 2024. Accessed [date].

Zhu

Ghitza

. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: results from electronic health records data. Drug Alcohol Depend. 2018;192:316-323. doi:10.1016/j.drugalcdep.2018.08.013

10.

Ramos

Wheaton

Johnson

. Sleep deprivation, sleep disorders, and chronic disease. Prev Chronic Dis. 2023;20:E77. doi:10.5888/pcd20.230197

11.

Mishra

Holt-Lunstad

Jones

. Social relationship satisfaction and accumulation of chronic conditions and multimorbidity: a national cohort of Australian women. Gen Psychiatry. 2023;36:e100925.

12.

Merin

Shaji

Kameswaran

. A review on sun exposure and skin diseases. Indian J Dermatol. 2022;67(5):625. doi:10.4103/ijd.ijd_1092_20

13.

Chen

Liu

Zhao

Qiu

. Oxidative stress in the skin: impact and related protection. Int J Cosmet Sci. 2021;43(5):495-509. doi:10.1111/ics.12728

14.

Gracia-Cazaña

Aguilera

Navarro-Bielsa

González

Lim

Gilaberte

. New trends on personalized sunscreens. Photodermatol Photoimmunol Photomed. 2024;40(3):e12967. doi:10.1111/phpp.12967

15.

Gonzalez

Carrillo

Lopez

, et al. Risk factors for failure of non-invasive ventilation in the treatment of respiratory failure exacerbations in obesity hipoventilation syndrome. Intensive Care Med. 2012;38:S75. doi:10.1007/s00134-012-2683-0

16.

Albrecht

Jung

Müller

, et al. Skin type differences in solar‐simulated radiation‐induced oxidative stress. Br J Dermatol. 2019;180(3):597-603. doi:10.1111/bjd.17129

17.

de Troya-Martín

Rodríguez-Martínez

Rivas-Ruiz

, et al. Personalized photoprotection: expert consensus and recommendations from a Delphi study among dermatologists. Photodermatol Photoimmunol Photomed. 2025;41(1):e70001. doi:10.1111/phpp.70001

18.

Sinha

Häder

. UV-induced DNA damage and repair: a review. Photochem Photobiol Sci. 2002;1(4):225-236. doi:10.1039/B201230H

19.

Modenese

Bisegna

Borra

, et al. Outdoor work and solar radiation exposure: evaluation method for epidemiological studies. Med Pr. 2016;67(5):577-587. doi:10.13075/mp.5893.00461

20.

Shetty

Taylor

Lim

. Personalized photoprotection: commentary on adjusting best practices in the treatment of melasma with a focus on patients with skin of color. J Am Acad Dermatol. 2023;89(3):635-636. doi:10.1016/j.jaad.2023.05.038

21.

Mahmoud

Ruvolo

Hexsel

, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010;130(8):2092-2097. doi:10.1038/jid.2010.95

22.

Passeron

Lim

Goh

, et al. Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel. J Eur Acad Dermatol Venereol. 2021;35(7):1460-1469. doi:10.1111/jdv.17242

23.

Korzeniowska

Cieślewicz

Chmara

Jabłecka

Pawlaczyk

. Photosensitivity reactions in the elderly population: questionnaire-based survey and literature review. Therapeut Clin Risk Manag. 2019;15:1111-1119. doi:10.2147/TCRM.S215308

24.

Fazel

Fenton

Braun

, et al. Tailored sun safety messages for outdoor workers. Saf Health Work. 2023;14(1):43-49. doi:10.1016/j.shaw.2023.01.001

25.

Hammond

Reeder

Gray

Bell

. Are workers or their workplaces the key to occupational sun protection? Health Promot J Aust. 2008;19(2):97-101. doi:10.1071/he08097

26.

Falcone

Richters

RJH

Uzunbajakava

van Erp

PEJ

van de Kerkhof

PCM

. Risk factors associated with sensitive skin and potential role of lifestyle habits: a cross-sectional study. Clin Exp Dermatol. 2017;42(6):656-658. doi:10.1111/ced.13133

27.

Amaro-Ortiz

Yan

D'Orazio

. Ultraviolet radiation, aging and the skin: prevention of damage by topical cAMP manipulation. Molecules. 2014;19(5):6202-6219. doi:10.3390/molecules19056202

28.

Puviani

Barcella

Milani

. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer. G Ital Dermatol Venereol. 2013;148(6):693-698.

29.

Moscarella

Argenziano

Longo

Aladren

. Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study. J Eur Acad Dermatol Venereol. 2017;31(9):e401-e403. doi:10.1111/jdv.14209

30.

Adler

DeLeo

. Allergic contact dermatitis. JAMA Dermatol. 2021;157(3):364. doi:10.1001/jamadermatol.2020.5639

31.

Novak

Baurecht

Schäfer

, et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol. 2008;128(6):1430-1435. doi:10.1038/sj.jid.5701190

32.

Burkemper

. Contact dermatitis, patch testing, and allergen avoidance. Mo Med. 2015;112(4):296-300.

33.

Nedorost

Hammond

. Art of prevention: allergic sensitization through damaged skin: atopic, occupational, and stasis dermatitis. Int J Womens Dermatol. 2020;6(5):381-383. doi:10.1016/j.ijwd.2020.08.004

34.

Kim

. Influences of environmental chemicals on atopic dermatitis. Toxicol Res. 2015;31(2):89-96. doi:10.5487/TR.2015.31.2.089

35.

Kantor

Silverberg

. Environmental risk factors and their role in the management of atopic dermatitis. Expet Rev Clin Immunol. 2017;13(1):15-26. doi:10.1080/1744666X.2016.1212660

36.

Kabashima

. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci. 2013;70(1):3-11. doi:10.1016/j.jdermsci.2013.02.001

37.

Kohli

Nedorost

. Inflamed skin predisposes to sensitization to less potent allergens. J Am Acad Dermatol. 2016;75(2):312-317.e1. doi:10.1016/j.jaad.2016.03.010

38.

Hjorth

Roed-Petersen

. Occupational protein contact dermatitis in food handlers. Contact Dermat. 1976;2(1):28-42. doi:10.1111/j.1600-0536.1976.tb02975.x

39.

Chu

Marks

Flamm

. Occupational contact dermatitis: common occupational allergens. Dermatol Clin. 2020;38(3):339-349. doi:10.1016/j.det.2020.02.002

40.

Olusegun

Martincigh

. Allergic contact dermatitis: a significant environmental and occupational skin disease. Int J Dermatol. 2021;60(9):1082-1091. doi:10.1111/ijd.15502

41.

Nixon

Roberts

Frowen

Sim

. Knowledge of skin hazards and the use of gloves by Australian hairdressing students and practising hairdressers. Contact Dermat. 2006;54(2):112-116. doi:10.1111/j.0105-1873.2006.00790.x

42.

Warshaw

Schlarbaum

Silverberg

, et al. Contact dermatitis to personal care products is increasing (but different!) in males and females: north American contact dermatitis group data, 1996-2016. J Am Acad Dermatol. 2021;85(6):1446-1455. doi:10.1016/j.jaad.2020.10.003

43.

Joshi

Maczuga

Flamm

. Examining occupational characteristics of patients with allergic contact dermatitis: a retrospective claims-based analysis. J Am Acad Dermatol. 2023;89(4):811-813. doi:10.1016/j.jaad.2023.05.060

44.

Spiewak

. Occupational dermatoses among Polish private farmers, 1991-1999. Am J Ind Med. 2003;43(6):647-655. doi:10.1002/ajim.10224

45.

Gawkrodger

Lewis

Shah

. Contact sensitivity to nickel and other metals in jewelry reactors. J Am Acad Dermatol. 2000;43(1 Pt 1):31-36. doi:10.1067/mjd.2000.107235

46.

Katta

Desai

. Diet and dermatology. J Clin Aesthet Dermatol. 2014;7(7):46-51.

47.

Anand

Laughter

Maymone

MBC

Dellavalle

. Holistic dermatology: an evidence-based review of modifiable lifestyle factor associations with dermatologic disorders. J Am Acad Dermatol. 2022;86(4):868-877. doi:10.1016/j.jaad.2020.04.108

48.

Assaf

Kelly

. Nutritional dermatology: optimizing dietary choices for skin health. Nutrients. 2024;17(1):60. doi:10.3390/nu17010060

49.

Sharma

Chaudhary

Khungar

, et al. Dietary influences on skin health in common dermatological disorders. Cureus. 2024;16(2):e55282. doi:10.7759/cureus.55282

50.

Ahmed

Mikail

. Diet and skin health: the good and the bad. Nutrition. 2024;119:112350. doi:10.1016/j.nut.2023.112350

51.

Michalak

Pierzak

Kręcisz

Suliga

. Bioactive compounds for skin health: a review. Nutrients. 2021;13(1):203. doi:10.3390/nu13010203

52.

Darvin

Sterry

Lademann

Vergou

. The role of carotenoids in human skin. Molecules. 2011;16(12):10491-10506. doi:10.3390/molecules161210491

53.

Schagen

Zampeli

Makrantonaki

Zouboulis

. Discovering the link between nutrition and skin aging. Dermatoendocrinol. 2012;4(3):298-307. doi:10.4161/derm.22876

54.

Park

. Role of micronutrients in skin health and function. Biomol Ther. 2015;23(3):207-217. doi:10.4062/biomolther.2015.003

55.

Mostafa

Hegazy

. Vitamin D and the skin: focus on a complex relationship: a review. J Adv Res. 2015;6(6):793-804. doi:10.1016/j.jare.2014.01.011

56.

Januszewski

Forma

Zembala

, et al. Nutritional supplements for skin health-a review of what should be chosen and why. Medicina. 2023;60(1):68. doi:10.3390/medicina60010068

57.

Yang

Zhou

Song

. A review of fatty acids influencing skin condition. J Cosmet Dermatol. 2020;19(12):3199-3204. doi:10.1111/jocd.13616

58.

Balić

Vlašić

Žužul

Marinović

Bukvić Mokos

. Omega-3 versus omega-6 polyunsaturated fatty acids in the prevention and treatment of inflammatory skin diseases. Int J Mol Sci. 2020;21(3):741. doi:10.3390/ijms21030741

59.

Zaborowski

Długosz

Błaszak

Szulc

Leis

. The role of quercetin as a plant-derived bioactive agent in preventive medicine and treatment in skin disorders. Molecules. 2024;29(13):3206. doi:10.3390/molecules29133206

60.

Khachemoune

. Flavonoids and their therapeutic applications in skin diseases. Arch Dermatol Res. 2023;315(3):321-331. doi:10.1007/s00403-022-02395-3

61.

Ogawa

Kinoshita

Shimada

Kawamura

. Zinc and skin disorders. Nutrients. 2018;10(2):199. doi:10.3390/nu10020199

62.

Al-Khafaji

Brito

Bin

. Zinc and zinc transporters in dermatology. Int J Mol Sci. 2022;23(24):16165. doi:10.3390/ijms232416165

63.

Lin

Sermersheim

Lee

PHU

Steinberg

. Zinc in wound healing modulation. Nutrients. 2017;10(1):16. doi:10.3390/nu10010016

64.

Ahuja

Lio

. The role of trace elements in dermatology: a systematic review. J Integr Dermatol. 2023. Published online May. 1. https://www.jintegrativederm.org/article/73228-the-role-of-trace-elements-in-dermatology-a-systematic-review. Accessed 4 May 2025.

65.

Nosewicz

Spaccarelli

Roberts

, et al. The epidemiology, impact, and diagnosis of micronutrient nutritional dermatoses part 1: zinc, selenium, copper, vitamin A, and vitamin C. J Am Acad Dermatol. 2022;86(2):267-278. doi:10.1016/j.jaad.2021.07.079

66.

Kesik

Dogan-Gunaydin

Fisunoglu

. The impact of diet on Hidradenitis Suppurativa severity: a cross-sectional case-control study. Medicina. 2024;60(12):2107. doi:10.3390/medicina60122107. Published 2024 Dec 23.

67.

Weir

Roman

Jiminez

, et al. Hidradenitis suppurativa and five key vitamins and minerals. Skin Appendage Disord. 2023;9(3):153-159. doi:10.1159/000528122

68.

Armstrong

Harskamp

Armstrong

. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013;149(1):84-91. doi:10.1001/2013.jamadermatol.406

69.

McDonald

Calabresi

. Occlusive vascular disease in psoriatic patients. N Engl J Med. 1973;288(17):912.

70.

Eichenfield

Tom

Berger

, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol. 2014;71(1):116-132. doi:10.1016/j.jaad.2014.03.023

71.

Podder

Jaiswal

Das

. Dietary strategies for chronic spontaneous urticaria: an evidence-based review. Int J Dermatol. 2023;62(2):143-153. doi:10.1111/ijd.15988

72.

Reynolds

Yeung

Cheng

, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. doi:10.1016/j.jaad.2023.12.017

73.

Payette

Whalen

Grant-Kels

. Nutrition and nonmelanoma skin cancers. Clin Dermatol. 2010;28(6):650-662. doi:10.1016/j.clindermatol.2010.03.033

74.

Fruit and vegetable intake and overall cancer risk in the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst. https://academic.oup.com/jnci/article-abstract/102/8/529/2516544?redirectedFrom=PDF&login=false. Accessed May 4, 2025.

75.

Yeh

Liu

Liao

Berger

Rao

. Exercise in dermatology: exercise's influence on skin aging, skin cancer, psoriasis, venous ulcers, and androgenetic alopecia. J Am Acad Dermatol. 2022;87(1):183-184. doi:10.1016/j.jaad.2022.02.048

76.

Afvari

Beck

Kazlouskaya

Afrahim

Valdebran

. Diet, sleep, and exercise in inflammatory skin diseases. Our Dermatol Online. 2023;14(4):430-435. doi:10.7241/ourd.20234.21

77.

Oizumi

Sugimoto

Aibara

. The potential of exercise on lifestyle and skin function: narrative review. JMIR Dermatol. 2024;7:e51962. doi:10.2196/51962

78.

Nilsson

Tarnopolsky

. Mitochondria and aging-the role of exercise as a countermeasure. Biology. 2019;8(2):40. doi:10.3390/biology8020040

79.

Jetté

Sidney

Blümchen

. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol. 1990;13(8):555-565. doi:10.1002/clc.4960130809

80.

Frankel

Han

Qureshi

. The association between physical activity and the risk of incident psoriasis. Arch Dermatol. 2012;148(8):918-924. doi:10.1001/archdermatol.2012.943

81.

Silverberg

Song

Pinto

, et al. Atopic dermatitis is associated with less physical activity in US adults. J Invest Dermatol. 2016;136(8):1714-1716. doi:10.1016/j.jid.2016.04.025

82.

American Academy of Dermatology Association . How your workout can affect your skin. https://www.aad.org/public/everyday-care/skin-care-secrets/routine/workout-skin-care. Accessed 26 April 2025.

83.

National Institute on Aging . Exercising with Chronic Conditions. National Institutes of Health. https://www.nia.nih.gov/health/exercise-and-physical-activity/exercising-chronic-conditions. Reviewed January 14, 2025. Accessed April 26, 2025.

84.

Mann

Gorai

Staubach-Renz

Goldust

. Sleep disorders in dermatology – a comprehensive review. J Dtsch Dermatol Ges. 2023;21:577-584.

85.

Samaniego

Alonso

Sohail

Mostaghimi

. Sleep in dermatologic conditions: a review. JAAD Rev. 2025;4:6-43. doi:10.1016/j.jdrv.2025.02.009

86.

Mitri

Lin

Waldman

Grant-Kels

. Effects of tobacco and vaping on the skin. Clin Dermatol. 2021;39(5):762-771. doi:10.1016/j.clindermatol.2021.05.004

87.

Yanbaeva

Dentener

Creutzberg

Wesseling

Wouters

EFM

. Systemic effects of smoking. Chest. 2007;131(5):1557-1566. doi:10.1378/chest.06-2179

88.

Armstrong

Fuller

Sockolov

Voyles

. Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms. Br J Dermatol. 2011;165(6):1162-1168. doi:10.1111/j.1365-2133.2011.10526.x

89.

Demierre

Brooks

Koh

Geller

. Public knowledge, awareness, and perceptions of the association between skin aging and smoking. J Am Acad Dermatol. 1999;41(1):27-30. doi:10.1016/s0190-9622(99)70401-9

90.

Nicita-Mauro

Lo Balbo

Mento

Nicita-Mauro

Maltese

Basile

. Smoking, aging and the centenarians. Exp Gerontol. 2008;43(2):95-101. doi:10.1016/j.exger.2007.06.011

91.

Knuutinen

Kokkonen

Risteli

, et al. Smoking affects collagen synthesis and extracellular matrix turnover in human skin. Br J Dermatol. 2002;146(4):588-594. doi:10.1046/j.1365-2133.2002.04694.x

92.

Yin

Morita

Tsuji

. Tobacco smoke extract induces age-related changes due to modulation of TGF-beta. Exp Dermatol. 2003;12(Suppl 2):51-56. doi:10.1034/j.1600-0625.12.s2.8.x

93.

Yin

Morita

Tsuji

. Alterations of extracellular matrix induced by tobacco smoke extract. Arch Dermatol Res. 2000;292(4):188-194. doi:10.1007/s004030050476

94.

Romita

Foti

Calogiuri

, et al. Contact dermatitis due to transdermal therapeutic systems: a clinical update. Acta Biomed. 2018;90(1):5-10. doi:10.23750/abm.v90i1.6563. Published 2018 Oct 26.

95.

Ortiz

Grando

. Smoking and the skin. Int J Dermatol. 2012;51(3):250-262. doi:10.1111/j.1365-4632.2011.05205.x

96.

Miot

LDB

da Costa

ALB

Matsuo

Stolf

Marques

MEA

. Association between solitary keratoacanthoma and cigarette smoking: a case-control study. Dermatol Online J. 2006;12(2):2.

97.

Leonardi-Bee

Ellison

Bath-Hextall

. Smoking and the risk of nonmelanoma skin cancer: systematic review and meta-analysis. Arch Dermatol. 2012;148(8):939-946. doi:10.1001/archdermatol.2012.1374

98.

Freedman

Sigurdson

Doody

Rao

Linet

. Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control. 2003;14(9):847-857. doi:10.1023/b:caco.0000003839.56954.73

99.

Armstrong

Harskamp

Dhillon

Armstrong

. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol. 2014;170(2):304-314. doi:10.1111/bjd.12670

100.

Akiyama

Seishima

Watanabe

Nakatani

Mori

Kitajima

. The relationships of onset and exacerbation of pustulosis palmaris et plantaris to smoking and focal infections. J Dermatol. 1995;22(12):930-934. doi:10.1111/j.1346-8138.1995.tb03948.x

101.

Jin

Yang

Zhang

, et al. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China. J Eur Acad Dermatol Venereol. 2009;23(2):132-137. doi:10.1111/j.1468-3083.2008.02951.x

102.

Garg

Papagermanos

Midura

Strunk

. Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the USA. Br J Dermatol. 2018;178(3):709-714. doi:10.1111/bjd.15939

103.

Miot

Bartoli Miot

Haddad

. Association between discoid lupus erythematosus and cigarette smoking. Dermatology. 2005;211(2):118-122. doi:10.1159/000086440

104.

Koskenmies

Järvinen

Onkamo

, et al. Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. Lupus. 2008;17(4):337-347. doi:10.1177/0961203307087403

105.

Jewell

McCauliffe

. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol. 2000;42(6):983-987. doi:10.1067/mjd.2000.103635

106.

Lai

Recke

Zillikens

Kasperkiewicz

. Influence of cigarette smoking on pemphigus – a systematic review and pooled analysis of the literature. J Eur Acad Dermatol Venereol. 2018;32(8):1256-1262. doi:10.1111/jdv.14886

107.

Kaklamani

Markomichelakis

Kaklamanis

. Could nicotine be beneficial for behçet's disease? Clin Rheumatol. 2002;21(4):341-342. doi:10.1007/s100670200090

108.

Smith

Fenske

. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol. 2000;43(1 Pt 1):1-16. doi:10.1067/mjd.2000.104512

109.

Malpas

Robinson

Maling

. Mechanism of ethanol-induced vasodilation. J Appl Physiol. 1990;68(2):731-734. doi:10.1152/jappl.1990.68.2.731

110.

Girard

Kumar

McAfee

. Hematologic Effects of Acute and Chronic Alcohol Abuse. Hematol.

111.

Jain

Shao

Stewart

Grant-Kels

. The effects of alcohol and illicit drug use on the skin. Clin Dermatol. 2021;39(5):772-783. doi:10.1016/j.clindermatol.2021.05.005

112.

Anand

Laughter

Maymone

MBC

Dellavalle

. Holistic dermatology: an evidence-based review of modifiable lifestyle factor associations with dermatologic disorders. J Am Acad Dermatol. 2022;86(4):868-877. doi:10.1016/j.jaad.2020.04.108

113.

Higgins

Du Vivier

AWP

. Alcohol abuse and treatment resistance in skin disease. J Am Acad Dermatol. 1994;30(6):1048. doi:10.1016/S0190-9622(09)80167-9

114.

Higgins

du Vivier

. Alcohol and the skin. Alcohol Alcohol. 1992;27(6):595-602.

115.

Kearney

Kirby

. Alcohol and psoriasis for the dermatologist: know, screen, intervene. Am J Clin Dermatol. 2022;23(6):881-890. doi:10.1007/s40257-022-00713-z

116.

Al Jefri

Newbury Birch

Muirhead

, et al. High prevalence of alcohol use disorders in patients with inflammatory skin diseases. Br J Dermatol. 2017;177(3):837-844. doi:10.1111/bjd.15497

117.

Iskandar

IYK

Lunt

Thorneloe

Cordingley

Griffiths

CEM

Ashcroft

on behalf the British Association of Dermatologists Biologics and Immunomodulators Register and Psoriasis Stratification to Optimise Relevant Therapy Study Groups . On behalf of the British association of dermatologists biologics and immunomodulators register and psoriasis stratification to optimise relevant therapy study groups. Alcohol misuse is associated with poor response to systemic therapies for psoriasis: findings from a prospective multicentre cohort study. Br J Dermatol. 2021;185(5):952-960. doi:10.1111/bjd.20577

118.

Freedman

Sigurdson

Doody

Mabuchi

Linet

. Risk of basal cell carcinoma in relation to alcohol intake and smoking. Cancer Epidemiol Biomarkers Prev. 2003;12(12):1540-1543.

119.

Millen

Tucker

Hartge

, et al. Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev. 2004;13(6):1042-1051.

120.

Marek-Jozefowicz

Czajkowski

Grzybowski

, et al. The brain–skin axis in Psoriasis—Psychological, psychiatric, hormonal, and dermatological aspects. Int J Mol Sci. 2022;23(2):669. doi:10.3390/ijms23020669

121.

Zhang

Zhao

Cao

Ren

Chen

. Role of stress in skin diseases: a neuroendocrine-immune interaction view. Brain Behav Immun. 2024;116:286-302. doi:10.1016/j.bbi.2023.12.005

122.

Altemus

Rao

Dhabhar

Ding

Granstein

. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol. 2001;117(2):309-317. doi:10.1046/j.1523-1747.2001.01373.x

123.

Gupta

. Psychiatric and psychological co-morbidity in patients with dermatologic disorders. Am J Clin Dermatol. 2003;4(12):833-842.

124.

Slominski

Zmijewski

Skobowiat

Zbytek

Slominski

Steketee

. Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol. 2012;212:1-115. v–vii.

125.

Dalgard

Gieler

Holm

JØ

Bjertness

Hauser

. Self-esteem and body satisfaction among late adolescents with acne: results from a population survey. J Am Acad Dermatol. 2008;59(5):746-751.

126.

Cohen

Kamarck

Mermelstein

. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385-396.

127.

Finlay

Khan

. Dermatology life quality index (DLQI)—A simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-216.

128.

Hellhammer

Wüst

Kudielka

. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34(2):163-171.

129.

Hughes

Watkins

Blumenthal

Kuhn

Sherwood

. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. J Psychosom Res. 2004;57(4):353-358.

130.

Fordham

Griffiths

Bundy

. A pilot study examining mindfulness-based cognitive therapy in psoriasis. Psychol Health Med. 2015;20(1):121-127. doi:10.1080/13548506.2014.902483

131.

Kabat-Zinn

Wheeler

Light

, et al. Influence of a mindfulness-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis. Psychosom Med. 1998;60(5):625-632.

132.

Hughes

Lin

Yap

, et al. The effect of mindfulness on quality of life among adults with chronic skin conditions: a systematic review and meta-analysis. Br J Dermatol. 2020;183(3):490-501.

133.

Montgomery

Norman

Messenger

Thompson

. The importance of mindfulness in psychosocial distress and quality of life in dermatology patients. Br J Dermatol. 2016;175(5):930-936. doi:10.1111/bjd.14719

134.

Evers

Duller

van der Valk

Kraaimaat

. Social support and adaptation to the disease in men and women with psoriasis. Int J Dermatol. 2005;44(9):743-748. doi:10.1111/j.1365-4632.2005.02306.x

135.

Finlay

Khan

. Dermatology life quality index (DLQI)—A simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-216. doi:10.1111/j.1365-2230.1994.tb01167.x

136.

Hughes

Waite

Hawkley

Cacioppo

. A short scale for measuring loneliness in large surveys: results from two population-based studies. Res Aging. 2004;26(6):655-672. doi:10.1177/0164027504268574

137.

Zimet

Dahlem

Zimet

Farley

. The multidimensional scale of perceived social support. J Pers Assess. 1988;52(1):30-41. doi:10.1207/s15327752jpa5201_2

138.

Ning

Zhang

Wang

Yan

. The association between social support and depression among patients with vitiligo in China. Front Psychol. 2022;13:939845. doi:10.3389/fpsyg.2022.939845

139.

Cheuk

Schlums

Gallais Serezal

, et al. CD49a expression defines tissue-resident CD8+ T cells poised for cytotoxic function in human skin. Immunity. 2017;46(2):287-300.

140.

Tang

Yang

Xiong

Zhang

. Current insights and future perspectives of ultraviolet radiation (UV) exposure: friends and foes to the skin and beyond the skin. Environ Int. 2024;185:108535. doi:10.1016/j.envint.2024.108535

Lifestyle Medicine for Dermatologic Disease: Emerging Evidence Through a Lens of Personalized Care

Abstract

Keywords

Introduction to Lifestyle Medicine

Methods

Results and Discussion

UV Exposure

Allergens

Diet

Exercise

Sleep

Smoking

Alcohol

Stress and Trauma

Social Support

Conclusion

Footnotes

Declaration of Conflicting Interests

Funding

ORCID iDs

Data Availability Statement

References